-
Je něco špatně v tomto záznamu ?
Special Techniques of Adjuvant Breast Carcinoma Radiotherapy
I. Kolářová, B. Melichar, J. Vaňásek, I. Sirák, J. Petera, K. Horáčková, D. Pohanková, Z. Šinkorová, O. Hošek, M. Vošmik
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
NLK
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
36612294
DOI
10.3390/cancers15010298
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Modern radiotherapy techniques are designed to permit reduced irradiation of healthy tissue, resulting in a diminished risk of adverse effects and shortened recovery times. Several randomized studies have demonstrated the benefits of increased dosage to the tumor bed area in combination with whole breast irradiation (WBI). Conventional WBI treatment following breast-conserving procedures, which required 5-7 weeks of daily treatments, has been reduced to 3-4 weeks when using hyperfractionated regimens. The dosage administration improves local control, albeit with poorer cosmesis. The method of accelerated partial breast irradiation (APBI) shortens the treatment period whilst reducing the irradiated volume. APBI can be delivered using intraoperative radiation, brachytherapy, or external beam radiotherapy. Currently available data support the use of external beam partial breast irradiation in selected patients. Modern radiotherapy techniques make it possible to achieve favorable cosmesis in most patients undergoing immediate breast reconstruction surgery, and studies confirm that current methods of external beam radiation allow an acceptable coverage of target volumes both in the reconstructed breast and in the regional lymphatic nodes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003294
- 003
- CZ-PrNML
- 005
- 20240724133358.0
- 007
- ta
- 008
- 230413s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/cancers15010298 $2 doi
- 035 __
- $a (PubMed)36612294
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kolářová, Iveta $u Department of Oncology and Radiotherapy, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic $u Faculty of Health Studies, Pardubice University, 532 10 Pardubice, Czech Republic
- 245 10
- $a Special Techniques of Adjuvant Breast Carcinoma Radiotherapy / $c I. Kolářová, B. Melichar, J. Vaňásek, I. Sirák, J. Petera, K. Horáčková, D. Pohanková, Z. Šinkorová, O. Hošek, M. Vošmik
- 520 9_
- $a Modern radiotherapy techniques are designed to permit reduced irradiation of healthy tissue, resulting in a diminished risk of adverse effects and shortened recovery times. Several randomized studies have demonstrated the benefits of increased dosage to the tumor bed area in combination with whole breast irradiation (WBI). Conventional WBI treatment following breast-conserving procedures, which required 5-7 weeks of daily treatments, has been reduced to 3-4 weeks when using hyperfractionated regimens. The dosage administration improves local control, albeit with poorer cosmesis. The method of accelerated partial breast irradiation (APBI) shortens the treatment period whilst reducing the irradiated volume. APBI can be delivered using intraoperative radiation, brachytherapy, or external beam radiotherapy. Currently available data support the use of external beam partial breast irradiation in selected patients. Modern radiotherapy techniques make it possible to achieve favorable cosmesis in most patients undergoing immediate breast reconstruction surgery, and studies confirm that current methods of external beam radiation allow an acceptable coverage of target volumes both in the reconstructed breast and in the regional lymphatic nodes.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Melichar, Bohuslav $u Department of Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, 779 00 Olomouc, Czech Republic
- 700 1_
- $a Vaňásek, Jaroslav $u Faculty of Health Studies, Pardubice University, 532 10 Pardubice, Czech Republic $u Oncology Centre, Multiscan, 532 03 Pardubice, Czech Republic
- 700 1_
- $a Sirák, Igor $u Department of Oncology and Radiotherapy, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000259723866 $7 xx0135409
- 700 1_
- $a Petera, Jiří $u Department of Oncology and Radiotherapy, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic
- 700 1_
- $a Horáčková, Kateřina, $d 1980- $u Faculty of Health Studies, Pardubice University, 532 10 Pardubice, Czech Republic $1 https://orcid.org/0000000232562011 $7 xx0146814
- 700 1_
- $a Pohanková, Denisa $u Department of Oncology and Radiotherapy, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic
- 700 1_
- $a Šinkorová, Zuzana $u Department of Radiobiology, Faculty of Military Health Sciences, University of Defence, 500 01 Hradec Králové, Czech Republic
- 700 1_
- $a Hošek, Oldřich $u Faculty of Health Studies, Pardubice University, 532 10 Pardubice, Czech Republic
- 700 1_
- $a Vošmik, Milan $u Department of Oncology and Radiotherapy, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Charles University, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000164977505 $7 xx0135408
- 773 0_
- $w MED00173178 $t Cancers $x 2072-6694 $g Roč. 15, č. 1 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36612294 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230413 $b ABA008
- 991 __
- $a 20240724133353 $b ABA008
- 999 __
- $a ok $b bmc $g 1922855 $s 1189501
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2022 $b 15 $c 1 $e 20221231 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
- LZP __
- $a Pubmed-20230413